Ted P. Szatrowski

14.0k citations
41 papers · 10.9k indexed · 3 hit papers · h-index 26
Topics
Chronic Myeloid Leukemia Treatments (7 papers)Chronic Lymphocytic Leukemia Research (6 papers)Aortic aneurysm repair treatments (6 papers)
Partner nations
United StatesJapanItaly

In The Last Decade

Ted P. Szatrowski

41 papers receiving 10.7k citations

Hit Papers

Validation of a combined comorbidity index199120262002201419941991201010002.0k3.0k4.0k5.0k

Peers

Ted P. Szatrowski
Comparison fields: 5 of 170
  • Surgery 2.4k
  • Pulmonary and Respiratory Medicine 2.0k
  • Molecular Biology 1.7k
  • Cardiology and Cardiovascular Medicine 1.6k
  • Hematology 1.5k
Replace Jodi B Segal with:
Jodi B Segal United States
David A. Roth United States
George A. Kaysen United States
Garabed Eknoyan United States
Paul T. Seed United Kingdom
Mark J. Sarnak United States
Ewa A. Jankowska Poland
Kai‐Uwe Eckardt Germany
Paul P. Carbone United States
Susan S. Jick United States
Ted P. Szatrowski relative to Jodi B Segal United States Jodi B Segal's profile →
Citations per field
00.5×2.6×
Jodi B Segal · 1×
Citations per year

Countries citing papers authored by Ted P. Szatrowski

Since Specialization
Citations

This map shows the geographic impact of Ted P. Szatrowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted P. Szatrowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted P. Szatrowski more than expected).

Fields of papers citing papers by Ted P. Szatrowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ted P. Szatrowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted P. Szatrowski. The network helps show where Ted P. Szatrowski may publish in the future.

Co-authorship network of co-authors of Ted P. Szatrowski

This figure shows the co-authorship network connecting the top 25 collaborators of Ted P. Szatrowski. A scholar is included among the top collaborators of Ted P. Szatrowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ted P. Szatrowski. Ted P. Szatrowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 86
2 37
3
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemiabreakdown →
1103
4 43
5 16
6 11
7 17
8 26
9 79
10 26
11 109
12 5
13 25
14 307
15 15
16
Validation of a combined comorbidity indexbreakdown →
5218
17 60
18 4
19 163
20 125

About Ted P. Szatrowski

Ted P. Szatrowski is a scholar working on Hematology, Genetics and Developmental Neuroscience, having authored 41 papers that have together received 10.9k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Aortic aneurysm repair treatments (6 papers). The work is most often cited by research in Hematology (1.5k citations), Geriatrics and Gerontology (534 citations) and Genetics (1.1k citations). Ted P. Szatrowski has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Jeffrey P. Gold, Mary E. Charlson, Janey C. Peterson, Carl Nathan, M E Charlson, Pamela Williams‐Russo, Gregg S. Hartman, Ross L. Prentice, Mark W. Mason and Hiroo Kato. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026